檢索結果 - Alice Tsai

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review

    Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review 由 Charlotte L. Deijen, Alice Tsai, T. W. A. Koedam, M. Veltcamp Helbach, Colin Sietses, Antonio M. Lacy, H. Jaap Bonjer, Jurriaan B. Tuynman

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer

    COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer 由 Charlotte L. Deijen, Simone Velthuis, Alice Tsai, Stella Mavroveli, Elly S.M. de Lange–de Klerk, Colin Sietses, Jurriaan B. Tuynman, Antonio M. Lacy, George B. Hanna, H. Jaap Bonjer

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with <i>MTAP</i> Deletion

    Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with <i>MTAP</i> Deletion 由 Kevin M. Cottrell, Kimberly J. Briggs, Alice Tsai, Matthew R. Tonini, Douglas A. Whittington, Shanzhong Gong, Colin Liang, Patrick McCarren, Minjie Zhang, Wenhai Zhang, Alan Huang, John P. Maxwell

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers

    TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers 由 Kimberly J. Briggs, Kevin M. Cottrell, Matthew R. Tonini, Alice Tsai, Minjie Zhang, Douglas A. Whittington, Wenhai Zhang, Steven A. Lombardo, Satoshi Yoda, Erik Wilker, Samuel R. Meier, Yi Yu, Teng Teng, Alan Huang, John P. Maxwell

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Physiologically‐Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective

    Physiologically‐Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective 由 Tycho Heimbach, Yuan Chen, Jun Chen, Vaishali Dixit, Neil Parrott, Sheila Annie Peters, Italo Poggesi, Pradeep Sharma, Jan Snoeys, Mohamad Shebley, Guoying Tai, Susanna Tse, Vijay Upreti, Ying‐Hong Wang, Alice Tsai, Binfeng Xia, Ming Zheng, Andy Z. X. Zhu, Stephen D. Hall

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with <i>MTAP</i>-Deleted Cancers

    Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with <i>MTAP</i>-Deleted Cancers 由 Kevin M. Cottrell, Kimberly J. Briggs, Douglas A. Whittington, Haris Jahić, Janid A. Ali, Charles B. Davis, Shanzhong Gong, Deepali Gotur, Lina Gu, Patrick McCarren, Matthew R. Tonini, Alice Tsai, Erik Wilker, Hongling Yuan, Minjie Zhang, Wenhai Zhang, Alan Huang, John P. Maxwell

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit

    Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit 由 Randal A. Byrn, Steven J.M. Jones, Hamilton B. Bennett, Chris Bral, Michael P. Clark, Marc Jacobs, Ann D. Kwong, Mark W. Ledeboer, Joshua R. Leeman, Colleen F. McNeil, Mark A. Murcko, Azin Nezami, Emanuele Perola, René Rijnbrand, Kumkum Saxena, Alice Tsai, Yi Zhou, Paul S. Charifson

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of Influenza

    Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of Influenza 由 Upul K. Bandarage, Michael P. Clark, Emanuele Perola, Huai Gao, Marc Jacobs, Alice Tsai, Jeffery Gillespie, Joseph M. Kennedy, François Maltais, Mark W. Ledeboer, Ioana Davies, Wenxin Gu, Randal A. Byrn, Kwame Nti Addae, Hamilton B. Bennett, Joshua R. Leeman, Steven M. Jones, Colleen O’Brien, Christine Memmott, Youssef L. Bennani, Paul S. Charifson

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: